Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-25-001952
Filing Date
2025-05-27
Accepted
2025-05-27 07:13:12
Documents
7
Period of Report
2025-05-27

Document Format Files

Seq Description Document Type Size
1 6-K zk2533265.htm 6-K 12256
2 REGISTRANT'S PRESS RELEASE DATED MAY 27, 2025; exhibit_1.htm EX-99 316690
3 REGISTRANT'S CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS AS OF MARCH 31, exhibit_2.htm EX-99 476031
4 REGISTRANT'S OPERATING AND FINANCIAL REVIEW AS OF MARCH 31, 2025 AND FOR THE THR exhibit_3.htm EX-99 251451
5 image0.jpg GRAPHIC 58587
6 image00001.jpg GRAPHIC 27798
7 image00003.jpg GRAPHIC 39876
  Complete submission text file 0001178913-25-001952.txt   1231547
Mailing Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871
Business Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35223 | Film No.: 25984181
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)